Iron toxicity in diseases of aging: Alzheimers disease, Parkinsons disease and atherosclerosis
Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans
174 Previous studies have reported the comprehensive effects of GLP-1RA on the CNS, which go beyond the levels of blood glucose modulation, but are associated with numerous metabolic aspects such as food intake and preference, 127,175 water intake, 176 energy expenditure, 177 body weight reduction, 178 pancreatic function, 132,179,180 hypertension, 181 stress, 182 addiction behaviors, 183,184 as well as neurodegenerative disorders, such as Alzheimer and Parkinson diseases
I Am Taking a GLP-1 Weight-Loss MedicationWhat Should I Know? JAMA Internal Medicine , vol